Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.68 |
| ▸ | MMP1 | P03956 | 1/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.52 |
| ▸ | MMP9 | P14780 | 1/20 | 0.52 |
| ▸ | MMP12 | P39900 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | AGXT | P21549 | 2/20 | 0.50 |
| ▸ | RXRA | P19793 | 1/20 | 0.49 |
| ▸ | RXRB | P28702 | 1/20 | 0.49 |
| ▸ | RXRG | P48443 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 3/20 | 0.48 |
| ▸ | MAOB | P27338 | 3/20 | 0.48 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.48 |
| ▸ | THRA | P10827 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL227301 | 0.88 | HCAR2 (0.51) | HCAR2CYP3A4ALDH1A1TSHRTHRB | |
| SCHEMBL29908312 | 0.84 | HCAR2 (0.50) | HCAR2ALDH1A1TSHRTHRBHPGD | |
| SCHEMBL150216 | 0.84 | HCAR2 (0.50) | HCAR2ALDH1A1TSHRTHRBHPGD | |
| SCHEMBL24172399 | 0.84 | HCAR2 (0.49) | HCAR2MMP1MMP2MMP9MMP12 | |
| SCHEMBL1898363 | 0.83 | HCAR2 (0.48) | HCAR2THRB | |
| SCHEMBL9555012 | 0.82 | HCAR2 (0.47) | HCAR2CYP3A4ALDH1A1TSHRTHRB | |
| SCHEMBL2029341 | 0.82 | IDO1 (0.51) | HCAR2IDO1MAOAMAOBTHRB | |
| SCHEMBL24270436 | 0.82 | HCAR2 (0.47) | HCAR2TSHRTHRBHTT | |
| SCHEMBL27781513 | 0.82 | HCAR2 (0.48) | HCAR2CYP3A4ALDH1A1TSHRTHRB | |
| SCHEMBL11739714 | 0.81 | HCAR2 (0.74) | HCAR2MMP1MMP2MMP9MMP12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12186974-B2 | Method of manufacturing a heat-shrink elastomeric element | HALLIBURTON ENERGY SERVICES, INC. (US) | 2025-01-07 | — | — | US | disclosed |
| CN-116262727-A | Tetra-substituted styrene axial chiral compound and synthesis method thereof | 南京理工大学 | 2023-06-16 | — | — | CN | disclosed |
| US-20230174506-A1 | (DI)AMINATION OF ACTIVATED ALLENE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR SYNTHESIS OF THE SAME | PURDUE RESEARCH FOUNDATION | 2023-06-08 | — | — | US | disclosed |
| US-20210323217-A1 | METHOD OF MANUFACTURING A HEAT-SHRINK ELASTOMERIC ELEMENT | HALLIBURTON ENERGY SERVICES, INC. | 2021-10-21 | — | — | US | disclosed |
| US-11065807-B2 | Method of manufacturing a heat-shrink elastomeric element | THE UNIVERSITY OF TEXAS SYSTEM BOARD OF REGENTS (US) | 2021-07-20 | — | — | US | disclosed |
| US-20190077070-A1 | HEAT-SHRINK ELASTOMERIC ELEMENTS MADE FROM SHAPE MEMORY POLYMERS | HALLIBURTON ENERGY SERVICES, INC. | 2019-03-14 | — | — | US | disclosed |
| US-8299191-B2 | Shape memory polymers and process for preparing | GEORGIA TECH RESEARCH CORP. (US) | 2012-10-30 | — | — | US | disclosed |
| EP-2491082-A1 | SHAPE MEMORY POLYMERS AND PROCESS FOR PREPARING | Georgia Tech Research Corporation (US) | 2012-08-29 | — | — | EP | disclosed |
| WO-2011049879-A1 | SHAPE MEMORY POLYMERS AND PROCESS FOR PREPARING | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-04-28 | — | — | WO | disclosed |
| US-20110092652-A1 | SHAPE MEMORY POLYMERS AND PROCESS FOR PREPARING | GEORGIA TECH RESEARCH CORPORATION | 2011-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174506-A1 | (DI)AMINATION OF ACTIVATED ALLENE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR SYNTHESIS OF THE SAME | NAAA, PAM, AANAT | HCAR2 1404/4885MMP1 4555/4885MMP2 4580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.